Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
|Articles|May 16, 2022

VIDA Introduces New AI-Enabled Biomarker Services

VIDA Diagnostics, Inc. is introducing a new suite of retrospective data analysis services for clinical trial sponsors in response to growing demand for precision data to optimize lung treatment trials.

Read more about the new servces here.


Related to this article